Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bosma

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Skeletal Radiology|April 25, 2019
<sup>18</sup>F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcomaS E Bosma, D Vriens, H Gelderblom, et al.
Clinical Endocrinology|April 23, 2002
Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacementP H N Oomen, J A M Beentjes, E Bosma, et al.
Diabetologia|March 15, 2003
Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathyJ D Lefrandt, E Bosma, P H N Oomen, et al.
Journal of the Neurological Sciences|September 11, 2013
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosisJudith M Sonder, Rebecca Holman, Dirk L Knol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2020
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein InhibitorsEmiel Leegwater, Anne Strik, Erik B Wilms, et al.
Trials|August 2, 2024
Efficacy of tranexamic acid versus placebo in reducing blood loss during burn excisional surgery: a multi-center, double-blind, parallel, randomized placebo-controlled clinical trial (TRANEX)R K Gigengack, J Slob, A Meij-de Vries, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2011
Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scalesJ M Sonder, L V A E Bosma, F A H van der Linden, et al.
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2014
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosisJudith M Sonder, Lisanne J Balk, Femke A H van der Linden, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 PatientsE Leegwater, D J A R Moes, L B E Bosma, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Skeletal Radiology|April 25, 2019
<sup>18</sup>F-FDG PET-CT versus MRI for detection of skeletal metastasis in Ewing sarcomaS E Bosma, D Vriens, H Gelderblom, et al.
Clinical Endocrinology|April 23, 2002
Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacementP H N Oomen, J A M Beentjes, E Bosma, et al.
Diabetologia|March 15, 2003
Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathyJ D Lefrandt, E Bosma, P H N Oomen, et al.
Journal of the Neurological Sciences|September 11, 2013
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosisJudith M Sonder, Rebecca Holman, Dirk L Knol, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2020
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein InhibitorsEmiel Leegwater, Anne Strik, Erik B Wilms, et al.
Trials|August 2, 2024
Efficacy of tranexamic acid versus placebo in reducing blood loss during burn excisional surgery: a multi-center, double-blind, parallel, randomized placebo-controlled clinical trial (TRANEX)R K Gigengack, J Slob, A Meij-de Vries, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2011
Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scalesJ M Sonder, L V A E Bosma, F A H van der Linden, et al.
British Journal of Clinical Pharmacology|January 17, 2026
Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous-venous extracorporeal membrane oxygenation (VV-ECMO): A case reportTom C Zwart, Emiel Leegwater, Thomas H Ottens, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 27, 2014
Toward the use of proxy reports for estimating long-term patient-reported outcomes in multiple sclerosisJudith M Sonder, Lisanne J Balk, Femke A H van der Linden, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 PatientsE Leegwater, D J A R Moes, L B E Bosma, et al.
Pageof 5